Escient Pharmaceuticals’ $120 Million Series C Financing

Wilson Sonsini Goodrich & Rosati advised NEA and Abingworth on the transaction.Escient Pharmaceuticals announced that it had raised $120 million through a Series C Financing led…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now